MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy
World Journal of Urology, 05/02/2011Roethke M et al.
MRI–guided biopsy (MR–GB) shows a high detection rate of clinically significant PCa in patients with previous negative trans–rectal–ultrasound–guided biopsy (TRUS–GB) and persisting suspicion for Prostate cancer (PCa). In univariate regression analysis, only serum prostate specific antigen (PSA) levels were predictive for a positive biopsy result. Number of preceding negative biopsies was not associated with the likelihood of a positive biopsy result
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.